A lawsuit was filed on behalf of investors in Impax Laboratories Inc (NASDAQ:IPXL) shares over alleged securities laws violations and NASDAQ:IPXL investors should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 11/14/2016 -- The Shareholders Foundarion announced that an investor, who purchased shares of Impax Laboratories Inc (NASDAQ:IPXL), filed a lawsuit in California over alleged violations of Federal Securities Laws by Impax Laboratories Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Impax Laboratories Inc (NASDAQ:IPXL) have certain options and for certain investors are short and strict deadlines running. Deadline: January 9, 2017. NASDAQ:IPXL investors should contact the Shareholders Foundation at firstname.lastname@example.org or call 858-779-1554.
Impax, a specialty pharmaceutical company, a strategic alliance agreement with Teva Pharmaceuticals Curacao N.V. to develop, manufacture, and distribute controlled release generic pharmaceutical products.
Theplaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that Impax and several of its pharmaceutical industry peers colluded to fix generic drug prices, thatthe foregoing conduct constituted a violation of U.S. antitrust laws, that consequently, Impax's revenues during the Class Period were in part the result of illegal conduct, and that as a result of the foregoing, Impax's public statements were materially false and misleading at all relevant times.
On November 3, 2016, media outlets reported that United States prosecutors may file criminal charges by the end of 2016 against Impax Laboratories Inc and several other pharmaceutical companies for unlawfully colluding to fix generic drug prices.
Shares of Impax Laboratories Inc (NASDAQ:IPXL) declined from as high as $50.42 per share in July 2015 to as low as $16.40 per share on November 3, 2016.
On November 7, 2016, NASDAQ:IPXL shares closed at $17.85 per share.
Those who purchased shares of Impax Laboratories Inc have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego